250 related articles for article (PubMed ID: 19380446)
1. Oxidative stress, obesity, and breast cancer risk: results from the Shanghai Women's Health Study.
Dai Q; Gao YT; Shu XO; Yang G; Milne G; Cai Q; Wen W; Rothman N; Cai H; Li H; Xiang Y; Chow WH; Zheng W
J Clin Oncol; 2009 May; 27(15):2482-8. PubMed ID: 19380446
[TBL] [Abstract][Full Text] [Related]
2. Major metabolite of F2-isoprostane in urine may be a more sensitive biomarker of oxidative stress than isoprostane itself.
Dorjgochoo T; Gao YT; Chow WH; Shu XO; Yang G; Cai Q; Rothman N; Cai H; Li H; Deng X; Franke A; Roberts LJ; Milne G; Zheng W; Dai Q
Am J Clin Nutr; 2012 Aug; 96(2):405-14. PubMed ID: 22760572
[TBL] [Abstract][Full Text] [Related]
3. Obesity, age, and oxidative stress in middle-aged and older women.
Dorjgochoo T; Gao YT; Chow WH; Shu XO; Yang G; Cai Q; Rothman N; Cai H; Li H; Deng X; Shrubsole MJ; Murff H; Milne G; Zheng W; Dai Q
Antioxid Redox Signal; 2011 Jun; 14(12):2453-60. PubMed ID: 21043829
[TBL] [Abstract][Full Text] [Related]
4. Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk.
Rossner P; Gammon MD; Terry MB; Agrawal M; Zhang FF; Teitelbaum SL; Eng SM; Gaudet MM; Neugut AI; Santella RM
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):639-44. PubMed ID: 16614103
[TBL] [Abstract][Full Text] [Related]
5. Urinary 15-F2t-isoprostane, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan.
Wu HC; Wang Q; Yang HI; Ahsan H; Tsai WY; Wang LY; Chen SY; Chen CJ; Santella RM
Carcinogenesis; 2008 May; 29(5):971-6. PubMed ID: 18310087
[TBL] [Abstract][Full Text] [Related]
6. Pre-diagnostic urinary 15-F
Ma X; Tan YT; Yang Y; Gao J; Li HL; Zheng W; Lan Q; Rothman N; Shu XO; Xiang YB
Int J Cancer; 2018 Oct; 143(8):1896-1903. PubMed ID: 29756347
[TBL] [Abstract][Full Text] [Related]
7. Urinary biomarkers of oxidative stress and breast cancer survival.
Nechuta S; Cai Q; Zheng Y; Milne GL; Cai H; Dai Q; Yang G; Zheng W; Lu W; Shu XO
Cancer Causes Control; 2014 Jun; 25(6):701-7. PubMed ID: 24820618
[TBL] [Abstract][Full Text] [Related]
8. Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F(2t)-Isoprostane (8-iso-PGF(2alpha)) by a stable isotope dilution mass spectrometric assay.
Morales CR; Terry ES; Zackert WE; Montine TJ; Morrow JD
Clin Chim Acta; 2001 Dec; 314(1-2):93-9. PubMed ID: 11718683
[TBL] [Abstract][Full Text] [Related]
9. Intra-person variation of urinary biomarkers of oxidative stress and inflammation.
Wu X; Cai H; Xiang YB; Cai Q; Yang G; Liu D; Sanchez S; Zheng W; Milne G; Shu XO
Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):947-52. PubMed ID: 20332256
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress in relation to diet and physical activity among premenopausal women.
Anderson C; Milne GL; Sandler DP; Nichols HB
Br J Nutr; 2016 Oct; 116(8):1416-1424. PubMed ID: 27725001
[TBL] [Abstract][Full Text] [Related]
11. Response of rat thoracic aorta to F(2)-isoprostane metabolites.
Cracowski JL; Camus L; Durand T; Devillier P; Guy A; Hardy G; Stanke-Labesque F; Rossi JC; Bessard G
J Cardiovasc Pharmacol; 2002 Mar; 39(3):396-403. PubMed ID: 11862119
[TBL] [Abstract][Full Text] [Related]
12. Changes in urinary dinor dihydro F(2)-isoprostane metabolite concentrations, a marker of oxidative stress, during and following asthma exacerbations.
Wu P; Roberts LJ; Shintani AK; Sheller JR; Minton PA; Higgins SB; Hartert TV
Free Radic Res; 2007 Sep; 41(9):956-62. PubMed ID: 17729112
[TBL] [Abstract][Full Text] [Related]
13. 2,3-Dinor-5,6-dihydro-15-F(2t)-isoprostane: a bioactive prostanoid metabolite.
Hou X; Roberts LJ; Taber DF; Morrow JD; Kanai K; Gobeil F; Beauchamp MH; Bernier SG; Lepage G; Varma DR; Chemtob S
Am J Physiol Regul Integr Comp Physiol; 2001 Aug; 281(2):R391-400. PubMed ID: 11448840
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease risk factors and oxidative stress among premenopausal women.
Anderson C; Milne GL; Park YM; Sandler DP; Nichols HB
Free Radic Biol Med; 2018 Feb; 115():246-251. PubMed ID: 29229550
[TBL] [Abstract][Full Text] [Related]
15. Increased urinary F2-isoprostanes in systemic sclerosis, but not in primary Raynaud's phenomenon: effect of cold exposure.
Cracowski JL; Carpentier PH; Imbert B; Cachot S; Stanke-Labesque F; Bessard J; Bessard G
Arthritis Rheum; 2002 May; 46(5):1319-23. PubMed ID: 12115239
[TBL] [Abstract][Full Text] [Related]
16. The effect of valproic acid on hepatic and plasma levels of 15-F2t-isoprostane in rats.
Tong V; Chang TK; Chen J; Abbott FS
Free Radic Biol Med; 2003 Jun; 34(11):1435-46. PubMed ID: 12757854
[TBL] [Abstract][Full Text] [Related]
17. 15-F-isoprostane and 5-F-isoprostane are not triggers of myocardial preconditioning.
Arnaud C; Cracowski JL; Hakim A; Durand T; Guy A; Godin-Ribuot D; Bessard G; Ribuot C
Clin Exp Pharmacol Physiol; 2005; 32(5-6):350-4. PubMed ID: 15854141
[TBL] [Abstract][Full Text] [Related]
18. Urinary F2-isoprostanes are not associated with increased risk of type 2 diabetes.
Il'yasova D; Morrow JD; Wagenknecht LE
Obes Res; 2005 Sep; 13(9):1638-44. PubMed ID: 16222068
[TBL] [Abstract][Full Text] [Related]
19. Telomere length, oxidative damage, antioxidants and breast cancer risk.
Shen J; Gammon MD; Terry MB; Wang Q; Bradshaw P; Teitelbaum SL; Neugut AI; Santella RM
Int J Cancer; 2009 Apr; 124(7):1637-43. PubMed ID: 19089916
[TBL] [Abstract][Full Text] [Related]
20. Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry.
Davies SS; Zackert W; Luo Y; Cunningham CC; Frisard M; Roberts LJ
Anal Biochem; 2006 Jan; 348(2):185-91. PubMed ID: 16309621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
